Allan joined Voyage Medical in late 2011 as President and CEO. Prior to joining the Company, he spent nine years as the Vice President of Global Marketing and Business Development for CryoCath Technologies. Allan was an integral member of the team that brought CryoCath from promising concept to commercial success, ultimately leading to the Company's acquisition by Medtronic Inc. in 2008 for $385M. Prior to CryoCath, Allan was the President of CareGivers Health Services, a leading home health care provider, as well as holding senior management positions at Lifeline Systems and Ingram & Bell. Allan started his career at Smith & Nephew, where he ultimately managed the Canadian healthcare division of the company. Allan attended The University of Calgary, where he received a B.S., Biology.

Michael joined Voyage Medical in 2008 as Chief Financial Officer. He is responsible for overseeing all finance and legal at the Company. Prior to joining Voyage, Michael worked as Vice President of Finance at Microchip Biotechnologies, Inc., where he led the team that raised both Series A and Series B financings for the company. Earlier in his career, Michael was a corporate attorney at Venture Law Group, Heller Erhman, and acted as in-house associate counsel for Novell where he focused on intellectual property and employment issues. Prior to receiving a J.D. degree from the J. Reuben Clark Law School at Brigham Young University, Michael worked for KPMG as a tax advisor and CPA.

Doug joined Voyage Medical in 2012 as our Vice President, Research & Development / Operations. Prior to joining the company he was Chief Technology/Operations Officer with Stereotaxis, where he spent 11 years leading research, development, and commercial operations for their interventional electrophysiology / cardiology magnetic navigation platform and cath lab display integration products. Prior to joining Stereotaxis, Mr. Bruce was Vice President, Product Development and Marketing, for Intuitive Surgical, a developer and manufacturer of computer-enhanced minimally invasive surgery systems, from 1997 to 2001. Prior to Intuitive Surgical, Mr. Bruce was a Vice President of Engineering at Acuson Corp, a manufacturer of diagnostic ultrasound systems. He has held positions in mechanical, process and manufacturing engineering at Tandon Corp, ISS Sperry Univac and IBM. Mr. Bruce received a M.S. in Mechanical Engineering from the University of Santa Clara and a B.S. in Mechanical Engineering from the University of California at Berkeley.

John joined Voyage Medical in 2009 and possesses more than 20 years of experience in the medical device industry and possesses extensive Regulatory Affairs and Clinical Research experience. Prior to joining Voyage, John held executive level positions with companies including as Nellcor Puritan-Bennett, Sola Optical, St. Jude Medical/Ventritex, ADAC Laboratories/Philips Medical Systems, BioVentrix and Guidant/Boston Scientific. John received a B.S., Mechanical Engineering from Purdue University and a Certificate in Clinical Trials Management from the University of California. He is also a certified Regulatory Affairs Professional (both U.S. and EU) and both a Certified Quality and Reliability Engineer.

Randy joined Voyage Medical in 2012 as Vice President, Sales & Marketing. Prior to joining Voyage, Mr. Jordan worked at Correx, Inc. a structural heart disease company as Vice President, Marketing and Business Development. Previously he was based in Western Europe with CryoCath/Medtronic as Global Director, Marketing and AFib Business Development. Mr. Jordan has more than 20 years' experience in the biopharmaceutical, medical, and device industries, leading strategic plan development, distribution agreements, mergers, acquisitions and divestitures. Mr. Jordan holds an International MBA from European University, a Bachelor of Business Administration from St. Francis Xavier University.

Dave joined Voyage in 2007 and has over 25 years of sales and marketing experience in the medical device industry. Previously, Dave held several management roles with Boston Scientific's Electrophysiology division where he was responsible for business development and clinical training with an emphasis on 3D electroanatomic mapping and ablation. Prior to Boston Scientific, Dave served as Director of Business Development for Cardiac Pathways Corporation.Prior to Cardiac Pathways, Dave held sales and consulting positions with several successful medical device companies including Quinton, Electrophysiology Corporation, E for M, Cardio Data Systems and U.S. Surgical Corp. Dave received a B.S., Economics & Communications degree from Susquehanna University.

Vahid founded Voyage Medical in 2006 and was CEO and President for five years. He has over 20 years of experience in the medical device industry. Vahid is also a co-founder and board member of Baxano, Inc., an orthopedic and spine company. Previously, Vahid co-founded and was President of USGI Medical Inc., a gastrointestinal device company. Prior to USGI, Vahid served as President and CEO of AngioTrax, founded in 1997. Earlier in his career, Vahid was at Gynecare, Inc. as VP of R&D, which was subsequently acquired by Johnson & Johnson. Vahid also helped found Cardiac Science, which developed an automatic defibrillator device. Vahid received B.A. and M.S. degrees in Electrical and Biomedical Engineering from the University of Texas at Austin. He has many scientific publications to his credit and is inventor on over 200 issued and pending patents.

Mark Foley sits on Voyage Medical's Board of Directors and is a Venture Partner of RWI Ventures, focusing on investments in medical devices. Since joining RWI, Mark has led investments in Chakshu, BaroSense and DermaCare, where he serves on the Board of all three companies. Prior to RWI Ventures, he spent 17 years in senior operating roles at both large and small start-up medical device companies, most recently founding and serving as CEO of cardiac device maker, Ventrica, which was acquired by Medtronic in 2004. Before Ventrica, Mark worked for leading device companies Perclose, Guidant, DVI and U.S. Surgical Corporation. Because of the breadth of his operating experience, Mr. Foley has an intimate understanding of all aspects of what it takes to make a start-up company successful. Mark received a Bachelor's Degree from the University of Notre Dame.

Dana Mead joined Kleiner Perkins Caufield & Byers as a partner in May 2005 to work in the firm's life sciences practice. He leverages experience accrued from his venture-funded, startup management roles and board participation to support entrepreneurs and innovators dedicated to making a real difference in the lives of millions suffering from life-limiting diseases. Dana serves on the boards of Apnicure, Awarepoint, Corventis, Inspire Medical Systems, Intersect ENT, Invuity, Navigenics, Pulmonx, Spiracur, Spinal Modulation, Teladoc and Voyage Medical.
For the past 30 years, Dana's career has focused on identifying new medical technologies, developing new markets and therapies, and building world-class management teams. He has worked with physician thought leaders around the world representing 12 medical specialties. Before joining KPCB, Dana was president of Guidant Vascular Intervention, a fully integrated billion-dollar division with more than 4,500 employees. He joined Guidant in 1992 and held positions of increasing responsibility during his tenure, including vice president and general manager, Cardiac & Vascular Surgery; vice president and general manager, Stents, Vascular Intervention Group; president, Japan and A/P Operations based in Tokyo; and vice president, Corporate Relations and Policy, with responsibility for investor relations, corporate communications, corporate marketing and public policy initiatives. Earlier in his career, Dana worked in various sales and marketing roles at Allergan, Inc. and Johnson & Johnson.
Dana formerly served as a director of the Cardiovascular Research Foundation, Aesthera (acquired by Solta [Nasdaq: SLTM]) and OtisMed (acquired by Stryker [Nasdaq: SYK]). He currently serves on the boards of the California Healthcare Institute and Lucile Packard Children's Hospital at Stanford University, and he is the former chair of the Lafayette College West Coast Advisory Council. A native of Connecticut, Dana received his B.A. degree from Lafayette College and holds an M.B.A from the University of Southern California.

Mark started in venture capital in 1987 with Brentwood Associates where he became a General Partner. Mark has been a founder or seed investor in numerous healthcare companies including Epocrates, Odyssey Healthcare, and Perclose. Mark has a BS in Engineering and a BA in Economics from Yale University. Mark also has an MBA from the Stanford Graduate School of Business.

Dr. R. Hardwin Mead has practiced cardiac electrophysiology and cardiology for over 25 years, primarily at Sequoia Hospital in Redwood City. He and Dr. Roger Winkle, another prominent Bay area cardiac electrophyisiologist, began the first private cardiac electrophysiology practice in the Bay Area. Their practice has performed over 2000 ablation procedures for atrial fibrillation. In addition to his clinical work, Hardwin has partnered with industry over the years, dating back to his role on the initial advisory board for Ventritex and has been a consultant to Medtronic for over 20 years and now sits on their Independent Physician Quality Panel. He has had advisory roles with early stage companies including Proteus Biomedical, Acumen Medical, AFx Medical, Cierra, InnerPulse, EBR, and he is on the executive board of iRhythm. Dr. Mead attended Northwestern University, graduating with a combined B.A. and M.S. degrees in Biochemistry, and received his M.D. degree from Stanford University Medical School.

Mr. Booth currently sits on the Board of Directors of three companies. Mr. Booth has over 28 years experience in marketing and general management in the pharmaceutical and medical device industries all while at Pfizer Inc., from which he retired in 1998. As Vice President, Marketing of the Roerig Division of U.S. Pharmaceuticals, he was responsible for all in-line product marketing, new product development and marketing services.
From 1981 to 1993, Mr. Booth held a number of senior positions in the International Division including Country Manager, The Netherlands, Senior Vice President, Medical and Marketing in Japan and Regional Director, Australia/New Zealand. In 1990, he returned to New York Headquarters as Vice President, International Pharmaceuticals where he led the new product development function for all countries outside the U.S. with additional responsibility for market research, business development and sales training. He was also a member of the Pfizer International Board of Directors.
In 1993 Mr. Booth was assigned a pivotal role in the restructuring and subsequent divestiture of the Medical Technology Group which included all of Pfizer's medical device businesses. He served as President and CEO of America Medical Systems (1993-1998), Schneider Americas (1994-1996) and Valleylab (1996-1997).
Mr. Booth has been a member of the Minnesota Business Partnership and is currently a member of the National Association of Corporate Directors (NACD). He also served in the U.S. Marine Corps from March, 1967 to June, 1970 achieving the rank of Captain. Mr. Booth received a B.S. (Honors) Business Administration from McMaster University, Hamilton, Canada and an MBA Marketing and Operations Research from Columbia University.